Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights
May 1, 4:31 PM
Gainers Pulmonx (NASDAQ:LUNG) shares rose 29.5% to $10.0 during Wednesday’s after-market session. The market value of their outstanding…

ALLK

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights
February 14, 9:05 AM
Gainers Cogent Biosciences (NASDAQ:COGT) shares rose 45.6% to $7.95 during Wednesday’s pre-market session. The company’s market cap stands…

ALLK

Read More
2 minute read
  • Analyst Ratings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Small Cap
  • Trading Ideas

Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday

By Avi Kapoor
January 17, 9:19 AM
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

ALLK

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights
January 17, 9:05 AM
Gainers Tivic Health Systems (NASDAQ:TIVC) stock rose 25.9% to $1.75 during Wednesday’s pre-market session. The market value of…

ACXP

Read More
3 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Gold Down 1%; PNC Financial Posts Upbeat Earnings

By Avi Kapoor
January 16, 3:14 PM
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 350 points on Tuesday. The Dow traded down 0.93% to 37,243.85 while the NASDAQ fell 0.58% to 14,885.45. The S&P 500 also fell, dropping, 0.66% to 4,752.36.

ALLK

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights
January 16, 1:31 PM
Gainers Vaxart (NASDAQ:VXRT) shares rose 37.5% to $0.77 during Tuesday’s regular session. The company’s market cap stands at…

ACRS

Read More
3 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks

Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue

By Avi Kapoor
January 16, 12:53 PM
U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling more than 150 points on Tuesday. The Dow traded down 0.46% to 37,421.80 while the NASDAQ fell 0.02% to 14,969.24. The S&P 500 also fell, dropping, 0.17% to 4,775.50.

ALLK

Read More
2 minute read
  • Markets
  • Penny Stocks
  • Top Stories

Trial Setback: Allakos Drops Lead Skin Disorder Candidate, Cuts Workforce By 50%

By Vandana Singh
January 16, 11:33 AM
Allakos reports disappointing topline data from phase 2 trials for lirentelimab in atopic dermatitis and chronic spontaneous urticaria. Company undergoes restructuring to focus on AK006, extending cash runway into mid-2026.

ALLK

Read More
3 minute read
  • Commodities
  • Earnings
  • Eurozone
  • Global
  • Intraday Update
  • Markets
  • News
  • Penny Stocks
  • Trading Ideas

Dow Dips 200 Points; Goldman Sachs Earnings Top Views

By Avi Kapoor
January 16, 10:49 AM
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ fell 0.69% to 14,869.02. The S&P 500 also fell, dropping, 0.53% to 4,758.60.

ALLK

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights
January 16, 9:05 AM
Gainers MorphoSys (NASDAQ:MOR) shares moved upwards by 15.1% to $9.9 during Tuesday’s pre-market session. The company’s market cap…

AHG

Posts pagination

1 2 … 6 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service